BioWorld

April 22, 2003

Changing CytRx Licenses Broad RNAi Technology From U-Mass

CytRx Corp. is changing by taking up the torch of RNA interference technology through license agreements with the University of Massachusetts Medical School. (BioWorld Today) Read More

Drug Delivery Firm Acusphere Raises $20M In Eighth Round

Drop-Out Deciduous Baby Teeth Find New Life Careers In Hitherto Unexpected Postnatal Stem Cells

Structural GenomiX Installing Platform As Part Of Lilly Alliance

Other News To Note

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for July 14, 2026.

AI-generated illustration of a neuron with tau protein aggregation

AAIC 2026: Age of amyloid is being joined by time of tau

BioWorld

The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 14, 2026

Celia trial: data strong, analysts skeptical

BioWorld

Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...